Phillips-Medisize Corp. (Hudson, WI) is running a four-shot work cell that integrates four parts into one, company officials said in interviews following a press conference at Medical Design and Manufacturing West at Anaheim, California. Three materials are introduced to the mold through three separate injection barrels, and the fourth shot takes place in the tool, Bill Welch, the company’s chief technology officer, said. Improved sealing as well as reduced assembly time are the main benefits of the part, which Welch described as a small electronic enclosure. Millions of the parts are being run annually.
The four-shot application was an example used by CEO Matt Jennings to illustrate the technology foundation of the company, which dates to a culture of innovation established by founder and longtime CEO Robert Cervanka who sold the company to Kohlberg & Co. in late 2010. Last year, Phillips merged with European medical contract manufacturer Medisize. Other important areas of technical innovation at Phillips-Medisize include powder injection molding, liquid silicone rubber molding, and automated near-press assembly.